  |
 |
|
    |
|
|
|
|
      
|
|
The NBA is pleased to confirm that the new arrangements for the supply of Red Cell Diagnostic Products for the period 1 July 2011 to 30 June 2014 have been finalised with five suppliers - Abacus ALS; Bio-RAD Laboratories; CSL Limited; Lateral Diagnostics; and Ortho-Clinical Diagnostics.
This Deed of Standing Offer replaced a similar arrangement that was in place since 2005, but with a range of further service improvements.
The Deed of Standing Offer lists more than 130 red cell diagnostic products, which are used in laboratory tests known as blood typing and cross matching. These tests ensure that when a person needs a blood transfusion, they receive blood that is compatible with their own.
The Standing Offer will continue to provide public pathology laboratories with a wide choice of products and the ability to procure the most appropriate diagnostic blood products at competitive prices, quality and service levels.
Documentation about the operation of the arrangements can be found below. Operating procedures to access the current Standing Offer are identical to current arrangements with the exception of some price changes. Laboratories should refer to the Operating Procedures and attached product list for details of these changes. Changes to the product list or other updates will be posted on this site as they occur.
| RTF Document (1.8MB) 
| RTF Document (57KB)
| RTF Document
| RTF Document (87KB)
| RTF Document (88KB)
| RTF Document (78KB)
Feedback | Privacy | Copyright | Disclaimer | Contact Us
This page last modified on June 29, 2011
